Factors associated with seizure in tramadol overdose: a 12-year retrospective study in Hong Kong

References

• Grond S, Sablotzki A. Clinical pharmacology of tramadol. Clin Pharmacokinet. 2004;43(13):879–923.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter evaluation of tramadol exposure. J Toxicol Clin Toxicol. 1997;35(4):361–364.
   PubMed Web of Science ®Google Scholar
• Shadnia S, Soltaninejad K, Heydari K, et al. Tramadol intoxication: a review of 114 cases. Hum Exp Toxicol. 2008;27(3):201–205.
   PubMed Web of Science ®Google Scholar
• Nakhaee S, Amirabadizadeh A, Brent J, et al. Tramadol and the occurrence of seizures: a systematic review and meta-analysis. Crit Rev Toxicol. 2019;49(8):710–723.
   PubMed Web of Science ®Google Scholar
• Jovanović-Čupić V, Martinović Ž, Nešić N. Seizures associated with intoxication and abuse of tramadol. Clin Toxicol. 2006;44(2):143–146.
   PubMed Web of Science ®Google Scholar
• Marquardt KA, Alsop JA, Albertson TE. Tramadol exposures reported to statewide poison control system. Ann Pharmacother. 2005;39(6):1039–1044.
   PubMed Web of Science ®Google Scholar
• Talaie H, Panahandeh R, Fayaznouri MR, et al. Dose-independent occurrence of seizure with tramadol. J Med Toxicol. 2009;5(2):63–67.
   PubMedGoogle Scholar
• Murray BP, Carpenter JE, Dunkley CA, et al. Seizures in tramadol overdoses reported in the ToxIC registry: predisposing factors and the role of naloxone. Clin Toxicol. 2019;57(8):692–696.
   PubMed Web of Science ®Google Scholar
• Rahimi HR, Soltaninejad K, Shadnia S. Acute tramadol poisoning and its clinical and laboratory findings. J Res Med Sci. 2014;19(9):855–859.
   PubMed Web of Science ®Google Scholar
• Goodarzi F, Mehrpour O, Eizadi-Mood N. A study to evaluate factors associated with seizure in tramadol poisoning in Iran. Indian J Forensic Med Toxicol. 2011;5(2):66–69.
   Google Scholar
• Ryan NM, Isbister GK. Tramadol overdose causes seizures and respiratory depression but serotonin toxicity appears unlikely. Clin Toxicol. 2015;53(6):545–550.
   PubMed Web of Science ®Google Scholar
• Okazi A, Taghaddosinejad F, Mazrouei N, et al. Occurrence and recurrence of seizures and related factors in patients with tramadol ingestion. Int J Med Toxicol Forensic Med. 2018;8(3):101–108.
   Web of Science ®Google Scholar
• Eizadi-Mood N, Ozcan D, Sabzghabaee AM, et al. Does naloxone prevent seizure in tramadol intoxicated patients? Int J Prev Med. 2014;5(3):302–307.
   PubMedGoogle Scholar
• Farzaneh E, Mostafazadeh B, Mehrpour O. Seizurogenic effects of low-dose naloxone in tramadol overdose. Indian J Pharmacol Therap. 2012;11(1):6–9.
   Google Scholar
• Hussien R, Elguindy MK. Assessment of the role of naloxone in the prognosis of tramadol intoxicated patients. J Clin Toxicol. 2017;7(7):1–5.
   Google Scholar
• Ahmadimanesh M, Shadnia S, Rouini MR, et al. Correlation between plasma concentrations of tramadol and its metabolites and the incidence of seizure in tramadol-intoxicated patients. Drug Metab and Pers Ther. 2018;33(2):75–83.
   PubMedGoogle Scholar
• Taghaddosinejad F, Mehrpour O, Afshari R, et al. Factors related to seizure in tramadol poisoning and its blood concentration. J Med Toxicol. 2011;7(3):183–188.
   PubMedGoogle Scholar
• Nasr M, Mahmoud S, Mohammed M, et al. A study of clinical and laboratory picture of acute tramadol toxicity in Damietta Governorate. Mansoura J Forensic Med Clini Toxicol. 2018;26(2):143–153.
   Google Scholar
• Rizk MMM, Kamal AM, Bakheet MAA, et al. Frequency and factors associated with occurrence of seizures in patients with tramadol abuse: an upper Egyptian experience. Addict Disord Their Treat. 2016;15(1):42–48.
   Web of Science ®Google Scholar
• Emamhadi M, Sanaei-Zadeh H, Nikniya M, et al. Electrocardiographic manifestations of tramadol toxicity with special reference to their ability for prediction of seizures. Am J Emerg Med. 2012;30(8):1481–1485.
   PubMed Web of Science ®Google Scholar
• Bradford LD. CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants. Pharmacogenomics. 2002;3(2):229–243.
   PubMed Web of Science ®Google Scholar
• Garcia-Barceló M, Chow LY, Chiu HFK, et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin Chem. 2000;46(1):18–23.
   PubMed Web of Science ®Google Scholar
• von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457.
   PubMed Web of Science ®Google Scholar
• Ghamsari AA, Dadpour B, Najari F. Frequency of electrocardiographic abnormalities in tramadol poisoned patients; a brief report. Emerg. 2016;4(3):151–154.
   PubMedGoogle Scholar
• Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual report of the American association of poison control centers’ national poison data system (NPDS): 37th annual report. Clin Toxicol. 2020;58(12):1360–1541.
   PubMed Web of Science ®Google Scholar
• Johansson I, Oscarson M, Yue QY, et al. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol. 1994;46(3):452–459.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Jeyaseelan K. Frequency of human CYP2D6 mutant alleles in a normal Chinese population. Br J Clin Pharmacol. 1994;37(6):605–607.
   PubMed Web of Science ®Google Scholar
• Wang SL, Lai MD, Huang JD. G169R mutation diminishes the metabolic activity of CYP2D6 in Chinese. Drug Metab Dispos. 1999;27(3):385–388.
   PubMed Web of Science ®Google Scholar
• Kantonen T, Karjalainen T, Isojärvi J, et al. Interindividual variability and lateralization of μ-opioid receptors in the human brain. Neuroimage. 2020;217:116922.
   PubMed Web of Science ®Google Scholar
• Zubieta J-K, Dannals RF, Frost JJ. Gender and age influences on human brain mu-opioid receptor binding measured by PET. Am J Psychiatry. 1999;156(6):842–848.
   PubMed Web of Science ®Google Scholar
• Zhao J, Xin X, Xie GX, et al. Molecular and cellular mechanisms of the age-dependency of opioid analgesia and tolerance. Mol Pain. 2012;8:38.
   PubMed Web of Science ®Google Scholar
• Bazmi E, Behnoush B, Hashemi Nazari S, et al. Seizure prediction model in acute tramadol poisoning; a derivation and validation study. Arch Acad Emerg Med. 2020;8(1):e59.
   PubMedGoogle Scholar
• Behnoush B, Bazmi E, Nazari S, et al. Machine learning algorithms to predict seizure due to acute tramadol poisoning. Hum Exp Toxicol. 2021;40(8):1225–1233.
   PubMed Web of Science ®Google Scholar
• Moghadam PH, Zarei N, Farsi D, et al. Electrocardiographic changes in patients with tramadol-induced idiosyncratic seizures. Turk J Emerg Med. 2016;16(4):151–154.
   PubMedGoogle Scholar
• Reimann W, Schneider F. Induction of 5-hydroxytryptamine release by tramadol, fenfluramine and reserpine. Eur J Pharmacol. 1998;349(2–3):199–203.
   PubMed Web of Science ®Google Scholar
• Murray BP, Carpenter JE, Dunkley CA, et al. In reply to Dr. Chhabra, Dr. Mégarbane, and colleagues. Clin Toxicol. 2019;57(12):1162–1163.
   PubMedGoogle Scholar
• Lagard C, Chevillard L, Malissin I, et al. Mechanisms of tramadol-related neurotoxicity in the rat: does diazepam/tramadol combination play a worsening role in overdose? Toxicol Appl Pharmacol. 2016;310:108–119.
   PubMed Web of Science ®Google Scholar
• Fujimoto Y, Funao T, Suehiro K, et al. Brain serotonin content regulates the manifestation of tramadol-induced seizure and serotonin syndrome. Anesthesiology. 2015;122(1):178–189.
   PubMed Web of Science ®Google Scholar
• García-Quetglas E, Azanza JR, Sádaba B, et al. Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype. Pharmacol Res. 2007;55(2):122–130.
   PubMed Web of Science ®Google Scholar
• Billeci L, Marino D, Insana L, et al. Patient-specific seizure prediction based on heart rate variability and recurrence quantification analysis. PLOS One. 2018;13(9):e0204339.
   PubMed Web of Science ®Google Scholar
• Jansen K, Varon C, Van Hu el S, et al. Peri-ictal ECG changes in childhood epilepsy: implications for detection systems. Epilepsy Behav. 2013;29(1):72–76.
   PubMed Web of Science ®Google Scholar
• Haeseler G, Foadi N, Ahrens J, et al. Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels. Pain. 2006;126(1):234–244.
   PubMed Web of Science ®Google Scholar
• Hara K, Minami K, Sata T. The effects of tramadol and its metabolite on glycine, gamma-aminobutyric acidA, and N-methyl-D-aspartate receptors expressed in xenopus oocytes. Anesth Analg. 2005;100(5):1400–1405.
   PubMed Web of Science ®Google Scholar
• Frenk H. Pro- and anticonvulsant actions of morphine and the endogenous opioids: involvement and interactions of multiple opiate and non-opiate systems. Brain Res. 1983;287(2):197–210.
   PubMedGoogle Scholar
• Raffa RB, Stone DJ. Unexceptional seizure potential of tramadol or its enantiomers or metabolites in mice. J Pharmacol Exp Ther. 2008;325(2):500–506.
   PubMed Web of Science ®Google Scholar
• Potschka H, Friderichs E, Löscher W. Anticonvulsant and proconvulsant effects of tramadol, its enantiomers and its M1 metabolite in the rat kindling model of epilepsy. Br J Pharmacol. 2000;131(2):203–212.
   PubMed Web of Science ®Google Scholar
• Rehni AK, Singh I, Kumar M. Tramadol-induced seizurogenic effect: a possible role of opioid-dependent γ-aminobutyric acid inhibitory pathway. Basic Clin Pharmacol Toxicol. 2008;103(3):262–266.
   PubMed Web of Science ®Google Scholar
• Vodovar D, Mégarbane B. Seizures induced by tramadol overdose: what is the respective contribution of tramadol and each of its metabolites? Drug Metab Pers Ther. 2019;34(1):20180025.
   Google Scholar
• Mégarbane B, Gouda AS, El-Nabarawy NA. Understanding the risk of seizure in tramadol overdose: still a long way to go. Clin Toxicol. 2019;57(12):1161–1162.
   PubMed Web of Science ®Google Scholar
• Eizadi-Mood N, Ghandehari M, Mansourian M, et al. Risk of seizure after naloxone therapy in acute tramadol poisoning: a systematic review with meta-analysis. Int J Prev Med. 2019;10:183.
   PubMed Web of Science ®Google Scholar
• Fournier JP, Azoulay L, Yin H, et al. Tramadol use and the risk of hospitalization for hypoglycemia in patients with noncancer pain. JAMA Intern Med. 2015;175(2):186–193.
   PubMed Web of Science ®Google Scholar
• Mugunthan N, Davoren P. Danger of hypoglycemia due to acute tramadol poisoning. Endocr Pract. 2012;18(6):e151–2–e152.
   PubMedGoogle Scholar
• Yamada J, Sugimoto Y, Kimura I, et al. Serotonin-induced hypoglycaemia and increased serum insulin levels in mice. Life Sci. 1989;45(20):1931–1936.
   PubMed Web of Science ®Google Scholar
• Cheng JT, Liu IM, Chi TC, et al. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes. 2001;50(12):2815–2821.
   PubMed Web of Science ®Google Scholar